KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 69 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40 | -9.1% | 4,215 | -14.1% | 0.00% | – |
Q2 2023 | $44 | -54.6% | 4,906 | -60.5% | 0.00% | – |
Q1 2023 | $97 | +115.6% | 12,413 | +88.9% | 0.00% | – |
Q4 2022 | $45 | -99.9% | 6,572 | +148.1% | 0.00% | – |
Q3 2022 | $38,000 | +100.0% | 2,649 | +34.5% | 0.00% | – |
Q2 2022 | $19,000 | -64.8% | 1,970 | -45.8% | 0.00% | – |
Q1 2022 | $54,000 | -93.0% | 3,638 | -93.7% | 0.00% | – |
Q4 2021 | $766,000 | +323.2% | 57,972 | +457.2% | 0.00% | – |
Q3 2021 | $181,000 | +48.4% | 10,404 | +105.2% | 0.00% | – |
Q2 2021 | $122,000 | -85.7% | 5,069 | -84.8% | 0.00% | – |
Q1 2021 | $854,000 | +228.5% | 33,283 | +143.3% | 0.00% | – |
Q4 2020 | $260,000 | +40.5% | 13,680 | -6.7% | 0.00% | – |
Q3 2020 | $185,000 | +9.5% | 14,658 | +4.7% | 0.00% | – |
Q2 2020 | $169,000 | +106.1% | 14,001 | +31.1% | 0.00% | – |
Q1 2020 | $82,000 | -81.5% | 10,679 | -57.1% | 0.00% | – |
Q4 2019 | $444,000 | +112.4% | 24,896 | +38.1% | 0.00% | – |
Q3 2019 | $209,000 | -59.0% | 18,034 | -21.6% | 0.00% | – |
Q2 2019 | $510,000 | -45.2% | 23,007 | -29.2% | 0.00% | -100.0% |
Q1 2019 | $930,000 | -25.0% | 32,489 | -48.2% | 0.00% | 0.0% |
Q4 2018 | $1,240,000 | +61900.0% | 62,778 | +88319.7% | 0.00% | – |
Q3 2018 | $2,000 | -84.6% | 71 | -94.7% | 0.00% | – |
Q4 2017 | $13,000 | – | 1,349 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |